ISOPTO ATROPINE Rx
Generic Name and Formulations:
Atropine sulfate 1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for ISOPTO ATROPINE:
For mydriasis and/or cycloplegia. For cycloplegic refraction, for papillary dilation desired in inflammatory conditions of the iris and uveal tract.
Compress lacrimal sac by digital pressure for 2–3 minutes after instillation to avoid excessive systemic absorption. Uveitis: 1–2 drops in the eye(s) up to 4 times daily. Heavily pigmented irides may require larger doses.
Primary glaucoma or tendency toward glaucoma (eg, narrow anterior chamber angle).
Previous susceptibility to belladonna alkaloids; excessive use may produce systemic symptoms of atropine poisoning. Estimate depth of angle of anterior chamber to avoid inducing angle closure glaucoma. Infants. Pregnancy (Cat.C). Nursing mothers.
Prolonged use: follicular conjunctivitis, vascular congestion, edema, exudate, eczematoid dermatitis; hypotension, progressive respiratory depression (with excessive systemic absorption); children: coma, death possible.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Rapid Cycling Bipolar Disorder Associated With ADHD and Female Gender
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Symptom Trajectories Vary According to Language Development in Autism
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children